focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,172.00
Bid: 12,168.00
Ask: 12,170.00
Change: -74.00 (-0.60%)
Spread: 2.00 (0.016%)
Open: 12,240.00
High: 12,306.00
Low: 12,132.00
Prev. Close: 12,172.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: UK Aims For 14 Million To Be Offered Covid Jab By Mid-Feb

Tue, 05th Jan 2021 06:49

(Alliance News) - Almost 14 million people in the UK could be in line for a Covid vaccine by the middle of February, in line with plans announced by the prime minister.

In a TV address announcing the third national lockdown for England, Boris Johnson said officials were hoping for all people in the top four priority groups to have been offered a jab in the coming weeks.

Tweeting afterwards, vaccine minister Nadhim Zahawi said the NHS "family will come together" to get 13.9 million doses prepared for the most vulnerable by the middle of next month.

A source told the PA news agency that those near the top of the list will be contacted by mid-February, but the final figure could be lower – closer to 13 million – because of some crossover between groups, such as those over 80 who live in care homes.

Speaking from Downing Street, Johnson outlined the NHS's "realistic expectations" for the vaccination programme in the coming weeks.

He said: "By the middle of February, if things go well and with a fair wind in our sails, we expect to have offered the first vaccine dose to everyone in the four top priority groups identified by the Joint Committee on Vaccination & Immunisation."

Theoretically, this means that all people over the age of 70 should expect to have an inoculation soon, as well as healthcare staff and others who are vulnerable.

Top of the priority list are people who live and work in care homes, followed by people over the age of 80 and frontline health and social care workers – including NHS staff.

Next on the list are people over the age 75, and the fourth group are people aged 70 and those classed as clinically extremely vulnerable.

This last group – who are the same as those who have been advised to shield – includes people such as organ transplant recipients and cancer patients.

Johnson said of the top four priority groups: "If we succeed in vaccinating all those groups, we will have removed huge numbers of people from the path of the virus".

"And of course that will eventually enable us to lift many of the restrictions we've endured for so long."

The news comes on the same day the first patients received the Oxford University and AstraZeneca PLC jab, which is now being handed out alongside the Pfizer Inc vaccine.

Johnson referred to the existence of the vaccines as the "one huge difference" in fighting the pandemic now compared to last year.

"We're now rolling out the biggest vaccination programme in our history," he added.

Hospitality businesses have pledged to help with the rollout, offering their spaces which are currently unused due to ongoing closures.

Calling for more grants as premises remain shuttered, UKHospitality Chief Executive Kate Nicholls said businesses are "keen to repay the support shown to us".

She explained: "Our sector is sitting on well-ventilated, Covid-secure spaces such as hotels, conference centres, pubs and restaurants which can be used and businesses are already coming forward to offer locations to expedite a mass vaccination programme."

By Caitlin Doherty, PA

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.